Abstract
With the increasing survival of cancer patients and therapeutic advancements, the cardiovascular complications of therapy have become a significant issue. A dedicated, integrated team is important in providing the balance between acquiring a hematological/oncological response and cardiovascular morbidity and mortality. This article aims to shed light on this field-providing some examples of therapies with cardiotoxic potential as well as the cardiologist's approach to patient assessment before, during, and after therapy.
| Original language | English |
|---|---|
| Pages (from-to) | 226-230 |
| Number of pages | 5 |
| Journal | Acta Haematologica |
| Volume | 140 |
| Issue number | 4 |
| DOIs | |
| State | Published - 1 Dec 2018 |
Keywords
- Cardio-hemato-oncology
- Cardiotoxicity
- Cardiovascular complications
